NCT05698173Recruiting
Systemic Lupus Erythematosus and Accelerated Aging
Source: ClinicalTrials.gov · Last updated 4 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The study aims at evaluating the phenomena of immune system aging in patients with Systemic lupus erythematosus.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 75 (estimated)
- First submitted
- 21 Dec 2022
- Start date
- 8 Sept 2023
- Primary completion date
- 30 Sept 2026
- Lead sponsor
- University Hospital, Bordeaux
- Diseases
- Lupus (SLE)
- NCT number
- NCT05698173
What you commit to
- Study type: Interventional
- Planned participants: 75
- From 8 Sept 2023 to the primary completion date, 30 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- persons deprived of their liberty by a judicial or administrative decision, minors, persons of legal age who are the object of a legal protection measure or unable to express their consent
Other
- pregnant or breastfeeding women;
Who the study is looking for
- male or female;
- age between 18 and 60 years;
- Lupus patient : diagnosis of systemic lupus erythematosus according to ACR or SLICC criteria;
- being affiliated to health insurance;
- willing to participate and to sign informed consent.
Age in the registry: 18 years to 60 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU de Bordeaux, Médecine interne et immunologie clinique Coordinator of this site? Confirm its status | Bordeaux | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.